Thomas Hatschek

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: BRITISH JOURNAL OF SURGERY. 2021;108(5):583-589
Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status
Zetterlund L; Celebioglu F; Hatschek T; Frisell J; de Boniface J
Article: ESMO OPEN. 2021;6(2):100076
bPrognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
Matikas A; Wang K; Lagoudaki E; Acs B; Zerdes I; Hartman J; Azavedo E; Bjohle J; Carlsson L; Einbeigi Z; Hedenfalk I; Hellstrom M; Lekberg T; Loman N; Saracco A; von Wachenfeldt A; Rotstein S; Bergqvist M; Bergh J; Hatschek T; Foukakis T
Article: ANNALS OF ONCOLOGY. 2020;31(10):1350-1358
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial
Montemurro F; Delaloge S; Barrios CH; Wuerstlein R; Anton A; Brain E; Hatschek T; Kelly CM; Pena-Murillo C; Yilmaz M; Donica M; Ellis P
Article: AMERICAN JOURNAL OF CANCER RESEARCH. 2020;10(8):2555-2569
Transcriptomic and functional pathway features were associated with survival after pathological complete response to neoadjuvant chemotherapy in breast cancer
Takeshita T; Yan L; Peng X; Kimbung S; Hatschek T; Hedenfalk IA; Rashid OM; Takabe K
Article: BREAST CANCER RESEARCH. 2019;21(1):36
Separation of breast cancer and organ microenvironment transcriptomes in metastases
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Article: MOLECULAR ONCOLOGY. 2019;13(2):376-391
Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer
Franzen B; Alexeyenko A; Kamali-Moghaddam M; Hatschek T; Kanter L; Ramqvist T; Kierkegaard J; Masucci G; Auer G; Landegren U; Lewensohn R
Article: PHARMACOGENOMICS. 2018;19(16):1259-1268
Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients
Sim S; Bergh J; Hellstroem M; Hatschek T; Xie H
Article: ONCOIMMUNOLOGY. 2018;7(9):e1466017
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
Matikas A; Lovrot J; Ramberg A; Eriksson M; Lindsten T; Lekberg T; Hedenfalk I; Loman N; Bergh J; Hatschek T; Erlandsson A; Foukakis T
Article: MOLECULAR ONCOLOGY. 2018;12(9):1415-1428
A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions
Franzen B; Kamali-Moghaddam M; Alexeyenko A; Hatschek T; Becker S; Wik L; Kierkegaard J; Eriksson A; Muppani NR; Auer G; Landegren U; Lewensohn R
Article: CELL. 2018;173(4):879-893.e13
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Kim C; Gao R; Sei E; Brandt R; Hartman J; Hatschek T; Crosetto N; Foukakis T; Navin NE
Article: BRITISH JOURNAL OF CANCER. 2018;118(4):480-488
Immune gene expression and response to chemotherapy in advanced breast cancer
Foukakis T; Lovrot J; Matikas A; Zerdes I; Lorent J; Tobin N; Suzuki C; Brage SE; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Ferno M; Skoog L; Bergh J; Hatschek T
Article: BMC CANCER. 2018;18(1):174
Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs)
Kjallquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stalhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(3):618-628
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
Kimbung S; Markholm I; Bjohle J; Lekberg T; von Wachenfeldt A; Azavedo E; Saracco A; Hellstrom M; Veerla S; Paquet E; Bendahl P-O; Ferno M; Bergh J; Loman N; Hatschek T; Hedenfalk I
Article: CLINICAL CANCER RESEARCH. 2017;23(23):7225-7231
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients
Tobin NP; Lundberg A; Lindstrom LS; Harrell JC; Foukakis T; Carlsson L; Einbeigi Z; Linderholm BK; Loman N; Malmberg M; Ferno M; Czene K; Perou CM; Bergh J; Hatschek T
Article: CANCER CELL. 2017;32(5):669-683.e5
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Palazon A; Tyrakis PA; Macias D; Velica P; Rundqvist H; Fitzpatrick S; Vojnovic N; Phan AT; Loman N; Hedenfalk I; Hatschek T; Lovrot J; Foukakis T; Goldrath AW; Bergh J; Johnson RS
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(45):E9635-E9644
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production
Nakamura M; Zhang Y; Yang Y; Sonmez C; Zheng W; Huang G; Seki T; Iwamoto H; Ding B; Yin L; Foukakis T; Hatschek T; Li X; Hosaka K; Li J; Yu G; Wang X; Liu Y; Cao Y
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;163(1):103-110
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Article: ACTA ONCOLOGICA. 2017;56(4):614-617
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen
Rosell J; Nordenskjold B; Bengtsson N-O; Fornander T; Hatschek T; Lindman H; Malmstrom P-O; Wallgren A; Stal O; Carstensen J
Article: ACTA RADIOLOGICA. 2017;58(4):394-402
Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy
Saracco A; Szabo BK; Tanczos E; Bergh J; Hatschek T
Article: THERAPEUTIC DRUG MONITORING. 2016;38(2):239-245
Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer
Fotoohi AK; Karim H; Lafolie P; Pohanka A; Ostervall J; Hatschek T; Vitols S
Article: CLINICAL CANCER RESEARCH. 2016;22(1):146-157
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer
Kimbung S; Johansson I; Danielsson A; Veerla S; Brage SE; Stolt MF; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmstrom P-O; Soderberg M; Walz TM; Ferno M; Hatschek T; Hedenfalk I
Article: ONCOTARGET. 2015;6(32):33306-33318
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications
Kimbung S; Kovacs A; Danielsson A; Bendahl P-O; Lovgren K; Stolt MF; Tobin NP; Lindstrom L; Bergh J; Einbeigi Z; Ferno M; Hatschek T; Hedenfalk I
Article: ANNALS OF ONCOLOGY. 2015;26(1):81-88
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
Tobin NP; Harrell JC; Lövrot J; Egyhazi Brage S; Frostvik Stolt M; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Walz T; Fernö M; Perou CM; Bergh J; Hatschek T; Lindström LS
Article: ACTA ONCOLOGICA. 2014;53(9):1197-1204
Audio-recorded information to patients considering participation in cancer clinical trials - a randomized study
Bergenmar M; Johansson H; Wilking N; Hatschek T; Brandberg Y
Article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2014;74(3):549-558
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide
von Stedingk H; Xie H; Hatschek T; Foukakis T; Ryden A; Bergh J; Rydberg P
Article: ANNALS OF PLASTIC SURGERY. 2014;73(1):105-113
When Is the Deep Inferior Epigastric Artery Flap Indicated for Breast Reconstruction in Patients not Treated With Radiotherapy?
Lundberg J; Thorarinsson A; Karlsson P; Ringberg A; Frisell J; Hatschek T; Kallstrom A-C; Elander A
Article: MOLECULAR ONCOLOGY. 2014;8(1):119-128
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences
Kimbung S; Kovacs A; Bendahl P-O; Malmstrom P; Ferno M; Hatschek T; Hedenfalk I
Article: BREAST. 2013;22(6):1142-1147
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel
Linderholm BK; Lidbrink E; Tallroth E; Einbeigi Z; Svensson H; von Wachenfeldt A; Norberg B; Carlsson L; Olsson ME; Bergh J; Wilking N; Hatschek T
Article: BREAST. 2013;22(5):634-638
Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer
Sharp L; Johansson H; Hatschek T; Bergenmar M
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2013;17(4):429-435
No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions - Results from a randomised blinded trial
Sharp L; Finnila K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;139(3):751-758
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
Bjohle J; Bergqvist J; Gronowitz JS; Johansson H; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Soderberg M; Sundquist M; Walz TM; Ferno M; Bergh J; Hatschek T
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;138(2):467-473
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
Rosell J; Nordenskjold B; Bengtsson N-O; Fornander T; Hatschek T; Lindman H; Malmstrom P-O; Wallgren A; Stal O; Carstensen J
Article: MEDICAL ONCOLOGY. 2013;30(1):415
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
Suzuki C; Blomqvist L; Hatschek T; Carlsson L; Einbeigi Z; Linderholm B; Lindh B; Loman N; Malmberg M; Rotstein S; Soderberg M; Sundqvist M; Walz TM; Astrom G; Fujii H; Jacobsson H; Glimelius B
Article: ANNALS OF ONCOLOGY. 2012;23:x349-x353
When to order a biopsy to characterise a metastatic relapse in breast cancer
Foukakis T; Astrom G; Lindstrom L; Hatschek T; Bergh J
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(21):2601-2608
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Lindstrom LS; Karlsson E; Wilking UM; Johansson U; Hartman J; Lidbrink EK; Hatschek T; Skoog L; Bergh J
Article: MEDICAL ONCOLOGY. 2012;29(2):432-438
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer
Svensson H; Hatschek T; Johansson H; Einbeigi Z; Brandberg Y
Article: BREAST CANCER RESEARCH AND TREATMENT. 2012;131(3):939-947
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
Hatschek T; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Lindh B; Loman N; Malmberg M; Rotstein S; Soderberg M; Sundquist M; Walz TM; Hellstrom M; Svensson H; Astrom G; Brandberg Y; Carstensen J; Ferno M; Bergh J
Article: BREAST. 2011;20(2):145-150
Pattern of care in locally advanced breast cancer: Focus on local therapy
Sinacki M; Badzio A; Welnicka-Jaskiewicz M; Bogaerts J; Piccart MJ; Therasse P; Smith IE; Hatschek T; Jassem J
Article: BRITISH JOURNAL OF CANCER. 2011;104(6):899-902
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
Rosell J; Nordenskjold B; Bengtsson N-O; Fornander T; Hatschek T; Lindman H; Malmstrom P-O; Wallgren A; Stal O; Carstensen J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;125(2):553-561
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
Wilking U; Karlsson E; Skoog L; Hatschek T; Lidbrink E; Elmberger G; Johansson H; Lindstrom L; Bergh J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2010;123(3):785-793
Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)
Svensson H; Einbeigi Z; Johansson H; Hatschek T; Brandberg Y
Article: ACTA ONCOLOGICA. 2010;49(4):509-514
Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria
Suzuki C; Torkzad MR; Jacobsson H; Astrom G; Sundin A; Hatschek T; Fujii H; Blomqvist L
Article: CANCER NURSING. 2009;32(1):55-63
Psychological Reactions to Progression of Metastatic Breast Cancer - An Interview Study
Svensson H; Brandberg Y; Einbeigi Z; Hatschek T; Ahlberg K
Article: ACTA ONCOLOGICA. 2009;48(6):860-866
Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer - A national survey performed at pathology departments in Sweden
Ryden L; Haglund M; Bendahl P-O; Hatschek T; Kolaric A; Kovacs A; Olsson A; Olsson H; Strand C; Ferno M
Article: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2008;134(2):125-135
A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
Baur M; van Oosterom AT; Dieras V; Tubiana-Hulin M; Coombes RC; Hatschek T; Murawsky M; Klink-Alakl M; Hudec M; Dittrich C
Article: CLINICAL MEDICINE: ONCOLOGY. 2008;2:533-538
Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study.
Einbeigi Z; Bergström D; Hatschek T; Malmberg M
Article: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2006;3(4):523-531
A five-year follow-up of quality of life in women with breast cancer in anthroposophic and conventional care
Carlsson M; Arman M; Backman M; Flatters U; Hatschek T; Hamrin E
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(21):1609-1610
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy:: Results from a randomized trial
Nordenskjöld B; Rosell J; Rutqvist LE; Malmström PO; Bergh J; Bengtsson NO; Hatschek T; Wallgren A; Carstensen J
Article: THE LANCET. 2005;365(9472):1687-1717
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
Abe O; Abe R; Enomoto K; Kikuchi K; Koyama H; Masuda H; Nomura Y; Sakai K; Sugimachi K; Tominaga T; Uchino J; Yoshida M; Haybittle JL; Davies C; Harvey VJ; Holdaway TM; Kay RG; Mason BH; Forbes JF; Wilcken N; Gnant M; Jakesz R; Ploner M; Yosef HMA; Focan C; Lobelle JP; Peek U; Oates GD; Powell J; Durand M; Mauriac L; Di Leo A; Dolci S; Piccart MJ; Masood MB; Parker D; Price JJ; Hupperets PSGJ; Jackson S; Ragaz J; Berry D; Broadwater G; Cirrincione C; Muss H; Norton L; Weiss RB; Abu-Zahra HT; Portnoj SM; Baum M; Cuzick J; Houghton J; Riley D; Gordon NH; Davis HL; Beatrice A; Mihura J; Naja A; Lehingue Y; Romestaing P; Dubois JB; Delozier T; Mace-Lesec'h J; Rambert P; Andrysek O; Barkmanova J; Owen JR; Meier P; Howell A; Ribeiro GC; Swindell R; Alison R; Boreham J; Clarke M; Collins R; Darby S; Davies C; Elphinstone P; Evans V; Godwin J; Gray R; Harwood C; Hicks C; James S; MacKinnon E; McGale P; McHugh T; Mead G; Peto R; Wang Y; Albano J; de Oliveira CF; Gervásio H; Gordilho J; Johansen H; Mouridsen HT; Gelman RS; Harris JR; Henderson IC; Shapiro CL; Andersen KW; Axelsson CK; Blichert-Toft M; Moller S; Mouridsen HT; Overgaard J; Overgaard M; Rose C; Cartensen B; Palshof T; Trampisch HJ; Dalesio O; de Vries EGE; Rodenhuis S; van Tinteren H; Comis RL; Davidson NE; Gray R; Robert N; Sledge G; Tormey DC; Wood W; Cameron D; Chetty U; Forrest P; Jack W; Rossbach J; Klijn JGM; Treurniet-Donker AD; van Putten WLJ; Costa A; Veronesi U; Bartelink H; Duchateau L; Legrand C; Sylvester R; van der Hage JA; van de Velde CJH; Cunningham MP; Catalano R; Creech RH; Bonneterre J; Fargeot P; Fumoleau P; Kerbrat P; Namer M; Jonat W; Kaufmann M; Schumacher M; von Minckwitz G; Bastert G; Rauschecker H; Sauer R; Sauerbrei W; Schauer A; Schumacher M; de Schryver A; Vakaet L; Belfiglio M; Nicolucci A; Pellegrini F; Sacco M; Valentini M; McArdle CS; Smith DC; Galligioni E; Boccardo F; Rubagotti A; Dent DM; Gudgeon CA; Hacking A; Erazo A; Medina JY; Izuo M; Morishita Y; Takei H; Fentiman IS; Hayward JL; Rubens RD; Skilton D; Graeff H; Jänicke F; Meisner C; Scheurlen H; Kaufmann M; von Fournier D; Dafni U; Fountzilas G; Klefstrom P; Blomqvist C; Saarto T; Margreiter R; Asselain B; Salmon RJ; Vilcoq JR; Arriagada R; Hill C; Laplanche A; Lê MG; Spielmann M; Bruzzi P; Montanaro E; Rosso R; Sertoli MR; Venturini M; Amadori D; Benraadt J; Kooi M; van de Velde AO; van Dongen JA; Vermorken JB; Castiglione M; Cavalli F; Coates A; Collins J; Forbes J; Gelber RD; Goldhirsch A; Lindtner J; Price KN; Rudenstam CM; Senn HJ; Bliss JM; Chilvers CED; Coombes RC; Hall E; Marty M; Borovik R; Brufman G; Hayat H; Robinson E; Wigler N; Bonadonna G; Camerini T; De Palo G; Del Vecchio M; Formelli F; Valagussa P; Martoni A; Pannuti F; Cocconi G; Colozza A; Camisa R; Aogi K; Takashima S; Abe O; Ikeda T; Inokuchi K; Kikuchi K; Sawa K; Sonoo H; Korzeniowski S; Skolyszewski J; Ogawa M; Yamashita J; Bonte J; Christiaens R; Paridaens R; Van den Boegart W; Martin P; Romain S; Hakes T; Hudis CA; Norton L; Wittes R; Giokas G; Kondylis D; Lissaios B; de la Huerta R; Sainz MG; Altemus R; Cowan K; Danforth D; Lichter A; Lippman M; O'Shaughnessy J; Pierce LJ; Steinberg S; Venzon D; Zujewski J; Paradiso A; De Lena M; Schittulli F; Myles JD; Pater JL; Pritchard KI; Nomura Y; Anderson S; Bass G; Brown A; Bryant J; Costantino J; Dignam J; Fisher B; Redmond C; Wieand S; Wolmark N; Baum M; Jackson IM; Palmer MK; Ingle JN; Suman VJ; Bengtsson NO; Jonsson H; Larsson LG; Lythgoe JP; Swindell R; Kissin M; Erikstein B; Hannisdal E; Jacobsen AB; Varhaug JE; Erikstein B; Gundersen S; Hauer-Jensen M; Host H; Jacobsen AB; Nissen-Meyer R; Blamey RW; Mitchell AK; Morgan DAL; Robertson JFR; Di Palma M; Mathé G; Misset JL; Clark RM; Levine M; Morimoto K; Sawa K; Takatsuka Y; Crossley E; Harris A; Talbot D; Taylor M; Cocconi G; di Blasio B; Ivanov V; Semiglazov V; Brockschmidt J; Cooper MR; Ueo H; Falkson CI; A'Hern R; Ashley S; Powles TJ; Smith IE; Yarnold JR; Gazet JC; Cocoran N; Deshpande N; di Martino L; Douglas P; Hacking A; Host H; Lindtner A; Notter G; Bryant AJS; Ewing GH; Firth LA; Krushen-Kosloski JL; Nissen-Meyer R; Foster L; George WD; Stewart HJ; Stroner P; Malmström P; Möller TR; Rydén S; Tengrup I; Tennvall-Nittby L; Carstenssen J; Dufmats M; Hatschek T; Nordenskjöld B; Söderberg M; Carpenter JT; Albain K; Crowley J; Green S; Martino S; Osborne CK; Ravdin PM; Glas U; Johansson U; Rutqvist LE; Singnomklao T; Wallgren A; Castiglione M; Goldhirsch A; Maibach R; Senn HJ; Thürlimann B; Brenner H; Hercbergs A; Yoshimoto M; DeBoer G; Paterson AHG; Pritchard KI; Meakin JW; Panzarella T; Pritchard KI; Shan Y; Shao YF; Wang X; Zhao DB; Boreham J; Chen ZM; Pan HC; Peto R; Bahi J; Reid M; Spittle M; Deutsch GP; Senanayake F; Kwong DLW; Bianco AR; Carlomagno C; De Laurentiis M; De Placido S; Buzdar AU; Smith T; Bergh J; Holmberg L; Liljegren G; Nilsson J; Seifert M; Sevelda P; Zielinsky CC; Buchanan RB; Cross M; Royle GT; Dunn JA; Hills RK; Lee M; Morrison JM; Spooner D; Litton A; Chlebowski RT; Caffier H
Article: ACTA ONCOLOGICA. 2004;43(1):27-34
Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care
Carlsson M; Arman M; Backman M; Flatters U; Hatschek T; Hamrin E
Article: BREAST CANCER RESEARCH AND TREATMENT. 2000;59(1):69-76
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group.
Fernö M; Stål O; Baldetorp B; Hatschek T; Källström AC; Malmström P; Nordenskjöld B; Rydën S
Article: ANTICANCER RESEARCH. 1999;19(4C):3383-3392
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.
Hultborn R; Gundersen S; Ryden S; Holmberg E; Carstensen J; Wallgren UB; Killany S; Andreassen L; Carlsson G; Fahl N; Hatschek T; Sommer HH; Hessman Y; Hornmark-Stenstam B; Johnsborg S; Klepp R; Laino R; Niklasson LG; Rudenstam CM; Sundbeck A; Söderberg M; Tejler G
Article: EUROPEAN JOURNAL OF CANCER. 1997;33(14):2393-2396
Frequent allelic losses on chromosome 13q in human male breast carcinomas.
Wingren S; van den Heuvel A; Gentile M; Olsen K; Hatschek T; Söderkvist P
Article: BREAST CANCER RESEARCH AND TREATMENT. 1997;44(1):39-46
Histopathology grading in small breast cancers < or = 10 mm--results from an area with mammography screening.
Arnesson LG; Hatschek T; Smeds S; Gröntoft O
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1997;336(14):980-987
Improved survival with preoperative radiotherapy in resectable rectal cancer
Pahlman L; Glimelius B; Cedermark B; Lundell G; Rubio C; Rutqvist LE; Wilking N; Ost A; Brismar B; Ewerth S; Forsgren L; Johansson C; Magnusson I; Sundelin P; Svensson C; Tornberg B; Theve T; Fenyo G; Svensson SO; Goldman S; Molin K; Bark S; Sundblad M; Dalen J; Lindholmer C; Robertsson B; Ohman U; Nilsson SE; Dahlberg M; Graf W; JanssonFrykholm G; Lindmark G; Westman M; Liljeholm H; Bendtsen O; Ljungquist U; Nihlberg A; Heuman R; Lorentz T; BisgaardPedersen A; Bergstrom S; Krog M; Tuvesson T; Edman P; Lindstrom C; Sandhammar B; Tyden G; Bergman L; Enander LK; Underskog I; Sellstrom H; Armatys P; Moell P; Hellberg R; Stenstam B; Dafnis G; Hojer H; Baldetorp L; Hatschek T; Sjodahl R; Arbman G; Nilsson E; StorgrenFordell V; Hugander A; Lagerberg F; Simert G; delaRue RA; Aldman A; Lannerstad O; Gullstrand P; Arwidi A; Bohe M; Ekelund G; Jiborn H; Landberg T; Graffman S; Jansson O; Jeppson B; Sorbris R; Ohlsson E; Lenninger S; Hallden K; Norryd C; Adamsen S; Hultborn R; Nilsson S; Magnusson O; Soderberg HE; Lindberg B; Tveit E; Jansson R; Svensson JH; Gustafsson A; Almskog B; Salander H; Holmlund D; Filipsson S; Laino R; Athlin L; Bengtsson NO; Groman G; Lundegard G; Dedorson S; Henriksson G; Nordahl A; Ryd G; Edlund G; Svensson JO; Rutegard J; Fagerberg M; Edin K
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1996;88(21):1543-1549
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Rutqvist LE; Hatschek T; Ryden S; Bergh J; Bengtsson NO; Carstenssen J; Nordenskjold B; Wallgren A
Article: THE LANCET. 1996;348(9036):1189-1196
Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Article: BRITISH JOURNAL OF CANCER. 1996;74(3):479-481
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor
Smith I; Jones A; Spielmann M; Namer M; Green MD; Bonneterre J; Wander HE; Hatschek T; Wilking N; Zalcberg J; Spiers J; Seymour L
Article: BRITISH JOURNAL OF SURGERY. 1996;162(5):397-402
Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial.
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1995;333(22):1444-1455
EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
ABE O; ABE R; ASAISHI K; ENOMOTO K; HATTORI T; IINO Y; KIKUCHI K; KOYAMA H; SAWA K; UCHINO J; YOSHIDA M; VANDEVELDE AO; VERMORKEN JB; FOROGLOU P; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; FORBES JF; FOCAN C; LOBELLE JP; PEEK U; OATES GD; POWELL J; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; CIRRINCIONE C; KORZUN A; WEISS RB; WOOD WC; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; HORGAN K; HUGHES L; STEWART HJ; GORDON NH; DAVIS HL; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; ABELOFF MD; CARBONE PC; GLICK J; GRAY R; TORMEY DC; BARTELINK H; FENTIMAN IS; PARIDAENS R; VANDRIEL OJR; SYLVESTER RJ; VANDEVELDE CJH; VANDERSCHUEREN E; VANDONGEN JA; WELVAART K; SCANLON EF; SCHURMAN S; DESCHRYVER A; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; KAUFMANN M; KLEFSTROM P; CUZICK J; MARGREITER R; CAVALLI F; COLLINS J; GELBER RD; GOLDHIRSCH A; ISLEY MR; LINDTNER J; PRICE KN; RUDENSTAM CM; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BRUFMAN G; HAYAT H; BOROVIK R; ROBINSON E; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; NOMURA Y; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; AHMANN D; SCHAID DJ; BUZDAR AU; SMITH T; HAKES T; NORTON L; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; BROWN A; FISHER B; REDMOND C; WOLMARK N; JACKSON IM; PALMER MK; INGLE JN; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; NAKAMURA Y; MATHE G; MISSET JL; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; DURRANT K; HARRIS A; BEIGHTON A; CHADBON D; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JAMES S; MEAD G; MULDAHL A; PETO R; TOOTH A; WHEATLEY K; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; NISSENMEYER R; FORREST APM; JACK W; MCDONALD C; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; OSBORNE CK; RUTQUIST LE; WALLGREN A; HOLM LE; CASTIGLIONE M; FLUCKIGER H; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; PRITCHARD KI; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLER M; SENANAYAKE F; HOLMBERG L; SEVELDA P; ZIELINSKY CC; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
Article: BRITISH JOURNAL OF CANCER. 1995;72(3):715-719
p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group.
Stenmark-Askmalm M; Stål O; Olsen K; Nordenskjöld B
Visa fler

Alla övriga publikationer

Published conference paper: RADIOGRAPHICS. 2008;28(2):329-344
Radiologic measurements of tumor response to treatment:: Practical approaches and limitations
Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Boden K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(9):1736-1742
Individuals with an increased risk of colorectal cancer: Perceived benefits and psychological aspects of surveillance by means of regular coloscopies
Liljegren A; Lindgren G; Brandberg Y; Rotstein S; Nilsson B; Hatschek T; Jaramillo E; Lindblom A
Published conference paper: CANCER. 1998;83(5):936-947
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide -: Prognostic and therapeutic implications
Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
Editorial comment: ACTA ONCOLOGICA. 1996;35(5):3-4
Nordic Ciba Cancer Care Workshop - Treatment of advanced breast cancer - Stockholm, January 18-19, 1996 - Foreword
Hatschek T; Blomqvist C; Lonning PE; Rose C
Published conference paper: ACTA ONCOLOGICA. 1996;35(5):75
Second-line endocrine treatment of advanced breast cancer - A randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide
Hultborn R; JohanssonTerje I; Bergh J; Glas U; Hallsten L; Hatschek T; Holmberg E; Idestrom K; Norberg B; Ranstam J; Soderberg M; Wallgren UB
Letter: AMERICAN JOURNAL OF EPIDEMIOLOGY. 1995;141(9):883-884
RE - DETERMINANTS OF PAPILLARY CANCER OF THE THYROID - REPLY
WINGREN G; AXELSON O; HATSCHEK T

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI